ÀÇ·áÁø ã±â
¾Æ·¡ °Ë»öÀ» ÅëÇØ Á¤È®ÇÏ°í ºü¸£°Ô ÀÇ·áÁøÀ» °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
Áø·á°ú ¾È³»
[¹®ÀÇÀüÈ] 1577-9966
Áø·á°ú¸¦ ¾È³»ÇØ µå¸³´Ï´Ù. Ŭ¸¯ ½Ã ÇØ´ç Áø·á°úÀÇ ÀÚ¼¼ÇÑ »çÇ×À» º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
Ç÷¾×³»°ú
-
[SCI]
Loeffler endocarditis in chronic eosinophilic leukemia with FIP1L1/PDGFRA rearrangement: full recovery with low dose imatinib
Kim DS, Lee SK, Choi CW
/ Loeffler endocarditis in chronic eosinophilic leukemia with FIP1L1/PDGFRA rearrangement: full recovery with low dose imatinib
/ 201706
-
[SCI]
Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma
Kim DS, Yu ES, Park Y, et al
/ Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma
/ 201611
-
[SCI]
Use of Deferasirox, an Iron Chelator, to Overcome Imatinib Resistance of Chronic Myeloid Leukemia Cells
Kim DS, Na YJ, Kang MH, et al
/ Use of Deferasirox, an Iron Chelator, to Overcome Imatinib Resistance of Chronic Myeloid Leukemia Cells
/ 31(2):357-66
/ 201603
-
[SCI]
Bone marrow vascular endothelial growth factor level per platelet count might be a significant predictor for the treatment outcomes of patients with diffuse large B-cell lymphomas
Kim JS, Kim DS, Kim BS, et al
/ Bone marrow vascular endothelial growth factor level per platelet count might be a significant predictor for the treatment outcomes of patients with diffuse large B-cell lymphomas
/ 45(10):914-20
/ 201510
-
[SCI]
Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines
Kim DS, Kang KW, Park Y, et al
/ Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines
/ 94(9):1485-92
/ 201509